Status
Conditions
Treatments
About
This study will investigate the impact of exercise on gastrointestinal function in peritoneal dialysis patients.
Full description
Maintaining gastrointestinal health is paramount for individuals on peritoneal dialysis, yet it frequently goes unnoticed within the broader scope of their health management. The effectiveness of dialysis treatments, along with aspects such as nutrient uptake and life quality, can be adversely affected by gastrointestinal disturbances. The volume of fluid within the peritoneal space, medications associated with dialysis, and the procedure of dialysis itself are all known to play roles in modulating gastrointestinal health.
The role of physical activity in enhancing gastrointestinal wellness among those with chronic conditions has gained acknowledgment over time. Customized exercise regimes have been shown to markedly better gastrointestinal symptoms, the efficiency of nutrient absorption, and overall life satisfaction among these patients. Notably, the specific influence of exercise on the gastrointestinal functions of individuals undergoing peritoneal dialysis has yet to be explored.
This investigation aims to assess the effects of exercise on the gastrointestinal health of peritoneal dialysis patients. Participants will be divided equally into an exercise group and a control group, following a randomized selection process. After collecting data throughout a four-month period, an analysis will be conducted to ascertain the benefits of physical activity for enhancing the gastrointestinal function of those on peritoneal dialysis. The outcomes of this study are anticipated to guide clinicians in recommending strategies to improve gastrointestinal health in this patient population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Recent systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg, or systolic blood pressure ≤90 mmHg or diastolic blood pressure ≤60 mmHg within the past week.
Presence of severe cardiovascular diseases, including but not limited to:
Severe pulmonary diseases, including but not limited to:
Presence of deep venous thrombosis.
Severe neurological, muscular, bone, or joint diseases that hinder compliance with exercise.
Participation in other concurrent exercise programs.
Primary purpose
Allocation
Interventional model
Masking
132 participants in 2 patient groups
Loading...
Central trial contact
Renjing Yang, Master; Jin Chen, Doctor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal